ATRIP and neoplasm: Among these, the natural compound Shikonin specifically induces proteasome‐dependent degradation of ATM‐ATR Interacting Protein (ATRIP), inhibiting the activation of upstream regulatory factors in the DDR signaling pathway, thereby enhancing the sensitivity of tumor cells to chemotherapeutic agents [70].